The accompanying table (click to enlarge) includes 32 companies in the ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks with market caps below $250M. I will maintain the index with these 32 components and track the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and regenerative medicine space.
Below is a list of all 32 companies in descending order by market cap with a total value of $1.27B and an average stock price change of -15% over the past year for the index, as compared to losses of 20% for the Healthcare Sector SPDR (XLV), 4.7% for SPDR S&P Biotech (XBI), 9.1% for iShares Nasdaq Biotech (IBB), and 18.9% for PowerShares Biotech & Genome (PBE).
StemCells (STEM)
BioMimetic Therapeutics (BMTI)
RTI Biologics (RTIX) – announced an $11.75M financing ($10M credit facility + $1.75M term loan) on Monday to replace its previous line of credit and supplement the Company's working capital needs.
Cytori Therapeutics (CYTX) – commenced patient enrollment last week in an investigator-initiated 10-patient study using adipose-derived stem cells processed by Cytori's Celution 800 System to treat stress urinary incontinence.
Aastrom Biosciences (ASTM)
Mesoblast (MBLTY)
BioTime (BTIM) – biggest stock gain in past year (up over 700%)
Osteotech (OSTE)
Neuralstem (CUR)
RegeneRx Biopharma (RGN)
ThermoGenesis (KOOL) – will report its fiscal 2Q09 results tomorrow with a conference call after the market close at 5 pm (ET).
Athersys (ATHX)
Advanced Cell Technology (ACTC)
International Stem Cell Corp (ISCO)
Bioheart (BHRT) – up over 20% today on news of a grant-funded study in Italy for the Bioheart A&C Bio Science Twin-Pulsatile Life Support System which is expected to be completed within just 45 days with the potential for $2.1M in contract sales if results are positive.
Pluristem Therapeutics (PSTI)
HepaLife Technologies (HPLF)
Stem Cell Innovations (SCLL)
Isolagen (ILE)
CellCyte Genetics Corp (CCYG)
Cryo-Cell (CCEL)
Stem Cell Therapeutics (SCTPF)
Brainstorm Cell Therapeutics (BCLI)
Stem Cell Authority (SCAL)
Opexa Therapeutics (OPXA)
Neostem (NBS)
Bio-Matrix Scientific Group (BMSN)
Cord Blood America (CBAI)
MediStem (MEDS)
Stem Cell Therapy Internt'l (SCII)
MultiCell Technologies (MCET)
LifeStem International (LSTM)
Via ETF Innovators, LLP:
Read the rest of original post »
